Cargando…
Adropin-based dual treatment enhances the therapeutic potential of mesenchymal stem cells in rat myocardial infarction
Both weak survival ability of stem cells and hostile microenvironment are dual dilemma for cell therapy. Adropin, a bioactive substance, has been demonstrated to be cytoprotective. We therefore hypothesized that adropin may produce dual protective effects on the therapeutic potential of stem cells i...
Autores principales: | Li, HuiYa, Hu, DanQing, Chen, Guilin, Zheng, DeDong, Li, ShuMei, Lin, YunLing, Hong, HuaShan, Luo, Yukun, Ke, YiLang, Huang, Yu, Wu, LingZhen, Lan, TingXiang, Wang, WenYing, Fang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131743/ https://www.ncbi.nlm.nih.gov/pubmed/34006853 http://dx.doi.org/10.1038/s41419-021-03610-1 |
Ejemplares similares
-
Adropin inhibits the progression of atherosclerosis in ApoE(-/-)/Enho(-/-) mice by regulating endothelial-to-mesenchymal transition
por: Ying, Teng, et al.
Publicado: (2023) -
Recombinant Extracellular Domain (p75ECD) of the Neurotrophin Receptor p75 Attenuates Myocardial Ischemia–Reperfusion Injury by Inhibiting the p‐JNK/Caspase‐3 Signaling Pathway in Rat Microvascular Pericytes
por: Fang, Jun, et al.
Publicado: (2020) -
Adropin – A new player in energy regulation predicts long-term prognosis of patients with acute myocardial infarction
por: Chang, Xiansong, et al.
Publicado: (2023) -
Serum Adropin Level in the Early Period of ST-Elevation Myocardial Infarction and Its Relationship With Cobalamin and Folic Acid
por: Adıyaman, Mehmet Şahin, et al.
Publicado: (2022) -
Adropin Alleviates Myocardial Fibrosis in Diabetic Cardiomyopathy Rats: A Preliminary Study
por: Liu, Mao, et al.
Publicado: (2021)